Modi Naturals Limited Reports Zero Physical Share Transfer Requests Under SEBI Special Window

1 min read     Updated on 13 Mar 2026, 11:28 AM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Modi Naturals Limited reported zero physical share transfer requests received, processed, approved, or rejected during February 5 to March 9, 2026 under SEBI's special window program. The report was prepared by Registrar Skyline Financial Services and submitted by Company Secretary Rajan Kumar Singh on March 13, 2026, in compliance with SEBI circular requirements for monthly reporting on transfer and dematerialization activities.

34927133

*this image is generated using AI for illustrative purposes only.

Modi Naturals Limited has filed its monthly compliance report with the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) regarding physical share transfer requests under the Securities and Exchange Board of India's (SEBI) special window program. The report covers the period from February 5, 2026 to March 9, 2026.

Zero Transfer Activity Reported

According to the official submission dated March 13, 2026, the company reported no activity in physical share transfers during the specified period. The comprehensive data shows:

Parameter Count
Requests received during the month 0
Requests processed during the month 0
Requests approved 0
Requests rejected 0
Average processing time (days) 0

Regulatory Compliance Framework

The report was submitted in accordance with SEBI Circular No. SEBI/HO/38/13/11(2)2026-MIRSD-POD/1/3750/2026 dated January 30, 2026. This circular relates to the "Ease of Doing Investment – Special Window for Transfer and Dematerialization of Physical Securities" initiative.

Report Preparation and Submission

The status report was prepared by Skyline Financial Services Private Limited, which serves as Modi Naturals Limited's Registrar and Transfer Agent. Pawan Singh Bisht, Assistant General Manager (Corporate Affairs) and Compliance Officer at Skyline Financial Services, compiled the monthly data from their New Delhi office.

Corporate Communication

Company Secretary and Compliance Officer Rajan Kumar Singh digitally signed and submitted the report to both stock exchanges on March 13, 2026. The submission was addressed to the Corporate Relationship Department at BSE Limited and the Listing Department at National Stock Exchange of India Limited.

The company trades under scrip code 519003 on BSE and symbol MODINATUR on NSE. This monthly reporting requirement ensures transparency in the transfer and dematerialization process of physical securities under SEBI's special window program.

Historical Stock Returns for Modi Naturals

1 Day5 Days1 Month6 Months1 Year5 Years
+1.90%+3.11%-14.55%-24.34%-24.34%-24.34%

Modi Naturals Limited Reports Q3FY26 Financial Results with Board Approval

3 min read     Updated on 14 Feb 2026, 07:13 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Modi Naturals Limited reported Q3FY26 financial results following Board approval on February 14, 2026, showing consolidated revenue of ₹17,409.31 lakhs and net profit growth of 28.67% year-on-year. The company demonstrated strong standalone performance with remarkable quarter-on-quarter improvements and significant contribution from its subsidiary Modi Biotech Private Limited.

32621580

*this image is generated using AI for illustrative purposes only.

Modi naturals Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, following a Board of Directors meeting held on February 14, 2026. The company submitted these results in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting and Regulatory Compliance

The Board of Directors meeting commenced at 04:05 PM IST and concluded at 06:15 PM IST on February 14, 2026. The Board approved the unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2025, and took on record the limited review report of the statutory auditors.

Meeting Details: Information
Meeting Date: February 14, 2026
Start Time: 04:05 PM IST
End Time: 06:15 PM IST
Compliance: Regulation 33 of SEBI LODR

The results will be published in newspapers as required under Regulation 47 of SEBI LODR Regulations and uploaded on the company's website at www.modinaturals.com .

Consolidated Financial Performance

The company's consolidated financial results demonstrate robust performance across key metrics for the quarter ended December 31, 2025:

Metric: Q3FY26 Q2FY26 Q3FY25 Change (QoQ) Change (YoY)
Revenue from Operations: ₹17,409.31 lakhs ₹14,698.62 lakhs ₹17,901.68 lakhs +18.45% -2.75%
Total Income: ₹17,412.72 lakhs ₹14,769.16 lakhs ₹17,979.83 lakhs +17.90% -3.15%
Net Profit: ₹1,005.84 lakhs ₹1,007.26 lakhs ₹781.81 lakhs -0.14% +28.67%
Total Comprehensive Income: ₹1,006.84 lakhs ₹1,008.61 lakhs ₹782.41 lakhs -0.18% +28.70%

For the nine-month period ended December 31, 2025, consolidated revenue from operations reached ₹47,610.81 lakhs compared to ₹47,322.86 lakhs in the corresponding period of the previous year, representing a marginal increase of 0.61%. Net profit for the nine-month period stood at ₹3,061.00 lakhs, showing significant growth from ₹2,286.49 lakhs in the previous year.

Standalone Financial Results

On a standalone basis, Modi Naturals Limited reported strong quarterly performance:

Parameter: Q3FY26 Q2FY26 Q3FY25 Nine Months FY26
Revenue from Operations: ₹9,298.81 lakhs ₹6,227.80 lakhs ₹9,729.55 lakhs ₹23,091.74 lakhs
Net Profit: ₹1,124.40 lakhs ₹262.76 lakhs ₹260.49 lakhs ₹699.16 lakhs
Earnings Per Share (Basic): ₹8.45 ₹1.97 ₹1.96 ₹5.25

The standalone results show remarkable quarter-on-quarter improvement, with revenue increasing by 49.33% and net profit surging by 327.87% compared to the previous quarter.

Segment Performance Analysis

Modi Naturals operates through two primary business segments - Branded and Bulk operations. The segment-wise performance for Q3FY26 reveals:

Segment: Revenue Q3FY26 Revenue Q2FY26 Nine Months FY26
Branded Business: ₹4,194.18 lakhs ₹4,628.86 lakhs ₹13,266.02 lakhs
Bulk Business: ₹5,104.63 lakhs ₹1,598.94 lakhs ₹9,825.72 lakhs
EBITDA - Branded: ₹384.62 lakhs ₹331.54 lakhs ₹1,104.94 lakhs

The Bulk Business segment demonstrated significant quarter-on-quarter growth of 219.35%, while the Branded Business maintained steady performance with strong profitability margins.

Subsidiary Performance and Auditor Review

The company's subsidiary, Modi Biotech Private Limited (100% holding), contributed significantly to consolidated performance with total revenues of ₹8,118.71 lakhs and net profit of ₹892.05 lakhs for the quarter. The subsidiary generated additional cash flow of ₹477.98 lakhs during Q3FY26 through GST input credit set-offs.

Doogar & Associates, Chartered Accountants, conducted the statutory audit and limited review of both standalone and consolidated financial statements. The auditors confirmed that nothing came to their attention that would suggest the financial results contain material misstatements or fail to comply with disclosure requirements under SEBI regulations.

Historical Stock Returns for Modi Naturals

1 Day5 Days1 Month6 Months1 Year5 Years
+1.90%+3.11%-14.55%-24.34%-24.34%-24.34%

More News on Modi Naturals

1 Year Returns:-24.34%